A health worker vaccinates a man in Abidjan during a roll-out of vaccinations against Ebola on August 17, 2021, after the country recorded its first known case of the disease since 1994. PHOTO | ISSOUF SANOGO | AFP
Trials on three separate vaccine regimens for the Ebola virus have returned positive results on their safety, promising an adequate roll-out of inoculation campaigns against one of the deadliest viral diseases.
The results from a large-scale randomised clinical trial on one of the candidate vaccines in West Africa also showed that the vaccine is capable of 12 months of protection against the viral disease.
